March 30, 2020
Noridian Healthcare Solutions, LLC via email: policydraft@noridian.com Attention: LCD Comments
PO Box 6781
Fargo, ND 58108-6781
Re: Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral
Compression Fracture (VCF) (L34228)
To Whom It May Concern:
On behalf of representatives of twelve medical specialty societies, comprising physicians
who utilize and/or perform percutaneous vertebral augmentation procedures, we would
like to take this opportunity to share comments regarding Noridian’s Local Coverage
Determination for Percutaneous Vertebral Augmentation for Osteoporotic Vertebral
Compression Fracture (L34228). We have significant concerns with the proposed LCD’s
exclusion from treatment all fractures over six weeks old and the requirement of a
multidisciplinary team. Below, we have suggested revisions to the covered indications and
exclusions/limitations sections, consistent with recommendations we have previously made to Novitas, First Coast, Palmetto, CGS, NGS, and WPS.
Read full letter here
